Cargando…
P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R-DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430754/ http://dx.doi.org/10.1097/01.HS9.0000847724.59361.c7 |
| _version_ | 1784779863074275328 |
|---|---|
| author | Cordoba, R. Falchi, L. Phillips, T. de Vos, S. Nijland, M. Offner, F. Bykhovski, I. Wu, J. Wang, L. Rana, A. Abrisqueta, P. |
| author_facet | Cordoba, R. Falchi, L. Phillips, T. de Vos, S. Nijland, M. Offner, F. Bykhovski, I. Wu, J. Wang, L. Rana, A. Abrisqueta, P. |
| author_sort | Cordoba, R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430754 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94307542022-08-31 P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R-DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT Cordoba, R. Falchi, L. Phillips, T. de Vos, S. Nijland, M. Offner, F. Bykhovski, I. Wu, J. Wang, L. Rana, A. Abrisqueta, P. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430754/ http://dx.doi.org/10.1097/01.HS9.0000847724.59361.c7 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Cordoba, R. Falchi, L. Phillips, T. de Vos, S. Nijland, M. Offner, F. Bykhovski, I. Wu, J. Wang, L. Rana, A. Abrisqueta, P. P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R-DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT |
| title | P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R-DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT |
| title_full | P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R-DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT |
| title_fullStr | P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R-DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT |
| title_full_unstemmed | P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R-DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT |
| title_short | P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R-DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT |
| title_sort | p1215: preliminary phase 1/2 results of subcutaneous epcoritamab + r-dhax/c in patients with relapsed or refractory diffuse large b-cell lymphoma eligible for autologous stem cell transplant |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430754/ http://dx.doi.org/10.1097/01.HS9.0000847724.59361.c7 |
| work_keys_str_mv | AT cordobar p1215preliminaryphase12resultsofsubcutaneousepcoritamabrdhaxcinpatientswithrelapsedorrefractorydiffuselargebcelllymphomaeligibleforautologousstemcelltransplant AT falchil p1215preliminaryphase12resultsofsubcutaneousepcoritamabrdhaxcinpatientswithrelapsedorrefractorydiffuselargebcelllymphomaeligibleforautologousstemcelltransplant AT phillipst p1215preliminaryphase12resultsofsubcutaneousepcoritamabrdhaxcinpatientswithrelapsedorrefractorydiffuselargebcelllymphomaeligibleforautologousstemcelltransplant AT devoss p1215preliminaryphase12resultsofsubcutaneousepcoritamabrdhaxcinpatientswithrelapsedorrefractorydiffuselargebcelllymphomaeligibleforautologousstemcelltransplant AT nijlandm p1215preliminaryphase12resultsofsubcutaneousepcoritamabrdhaxcinpatientswithrelapsedorrefractorydiffuselargebcelllymphomaeligibleforautologousstemcelltransplant AT offnerf p1215preliminaryphase12resultsofsubcutaneousepcoritamabrdhaxcinpatientswithrelapsedorrefractorydiffuselargebcelllymphomaeligibleforautologousstemcelltransplant AT bykhovskii p1215preliminaryphase12resultsofsubcutaneousepcoritamabrdhaxcinpatientswithrelapsedorrefractorydiffuselargebcelllymphomaeligibleforautologousstemcelltransplant AT wuj p1215preliminaryphase12resultsofsubcutaneousepcoritamabrdhaxcinpatientswithrelapsedorrefractorydiffuselargebcelllymphomaeligibleforautologousstemcelltransplant AT wangl p1215preliminaryphase12resultsofsubcutaneousepcoritamabrdhaxcinpatientswithrelapsedorrefractorydiffuselargebcelllymphomaeligibleforautologousstemcelltransplant AT ranaa p1215preliminaryphase12resultsofsubcutaneousepcoritamabrdhaxcinpatientswithrelapsedorrefractorydiffuselargebcelllymphomaeligibleforautologousstemcelltransplant AT abrisquetap p1215preliminaryphase12resultsofsubcutaneousepcoritamabrdhaxcinpatientswithrelapsedorrefractorydiffuselargebcelllymphomaeligibleforautologousstemcelltransplant |